Does DARATUMUMAB Cause Hepatitis b? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Hepatitis b have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.1% of all adverse event reports for DARATUMUMAB.
30
Reports of Hepatitis b with DARATUMUMAB
0.1%
of all DARATUMUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Hepatitis b From DARATUMUMAB?
Of the 30 reports, 3 (10.0%) required hospitalization.
Is Hepatitis b Listed in the Official Label?
Yes, Hepatitis b is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Hepatitis b?
RITUXIMAB (597)
CYCLOPHOSPHAMIDE (578)
LAMIVUDINE (480)
DOXORUBICIN (469)
VINCRISTINE (431)
PREDNISOLONE (371)
TENOFOVIR DISOPROXIL (257)
PREDNISONE (208)
DEXAMETHASONE (173)
ENTECAVIR (166)
Which DARATUMUMAB Alternatives Have Lower Hepatitis b Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE